Form 4: Cognex Corp Executive Dennis Fehr Reports Stock Option and Restricted Stock Unit Grants
SEC Form 4
Dennis Fehr, SVP and CFO of Cognex Corp, reports the acquisition of stock options and restricted stock units.
Summary
- On February 18, 2025, Dennis Fehr, the SVP and Chief Financial Officer of Cognex Corp, reported transactions related to derivative securities.
- Fehr acquired 68,823 non-qualified stock options with an exercise price of $33.04, exercisable starting February 18, 2026, and expiring on February 18, 2035.
- He also acquired 25,424 restricted stock units, vesting in installments starting February 18, 2026, and ending February 18, 2028.
- Fehr also holds 92,092 non-qualified stock options with an exercise price of $44.49, exercisable from May 6, 2028, and expiring on May 6, 2034.
- Additionally, he holds 17,982 restricted stock units, vesting from May 6, 2025, to May 6, 2027.
- Fehr directly owns 6,570 shares of Cognex Corp common stock.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of executive compensation and does not contain information that would significantly impact investor sentiment positively or negatively.
Positives
- The grant of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedules of the options and restricted stock units encourage long-term commitment from the executive.
Industry Context
Executive compensation practices are common across publicly traded companies to incentivize performance and retain key personnel. Stock options and restricted stock units are frequently used components of compensation packages.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the technology sector, aligning executive incentives with shareholder value.
- Companies like Keyence, and Omron, which are competitors of Cognex, also utilize stock options and restricted stock units as part of their executive compensation plans.
- The vesting schedules and exercise prices are generally in line with industry norms for companies of Cognex's size and market capitalization.
Stakeholder Impact
- The grant of stock options and restricted stock units could potentially increase shareholder value if the executive's performance leads to company growth.
- Employees may view the executive compensation package as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of transaction: Grant of stock options and restricted stock units. |
| 02/18/2026 | First vesting date for a portion of the non-qualified stock options and restricted stock units. |
| 02/18/2028 | Final vesting date for the restricted stock units granted on February 18, 2025. |
| 05/06/2025 | First vesting date for a portion of the restricted stock units granted on May 6, 2028. |
| 05/06/2027 | Final vesting date for the restricted stock units granted on May 6, 2028. |
| 05/06/2028 | First exercisable date for the non-qualified stock options granted on May 6, 2028. |
| 02/18/2035 | Expiration date for the non-qualified stock options granted on February 18, 2025. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.